Clostridium Diagnostics Market - Top Companies and Manufacturers

  • Report ID: 5472
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Clostridium Diagnostics Market

    • Cerebriu
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Diazyme Laboratories, Inc.
    • BioMerieux
    • Beckman Coulter, Inc.
    • F. Hoffmann-La Roche
    • Chrono-log Corporation
    • Hikma Pharmaceutical PLC
    • Pfizer Inc.
    • Baxter
    • DiaSorin SpA

Browse Key Market Insights with Data Illustration:

In the News

  • Cerebriu, a company that offers artificial intelligence (AI) solutions for streamlining radiology processes, and Siemens Healthineers, the top producer of magnetic resonance imaging (MRI) scanners worldwide, have partnered to incorporate Cerebriu's unique Smart ProtocolTM for Brain MRI-workflow automation software into Siemens Healthineers' MRI equipment.
  • Diazyme Laboratories and Maccura Biotechnology announced a collaboration to launch an FDA EUA-approved SARS-COV-2 RT-PCR diagnostic test. Located in Poway, California, Diazyme Laboratories Inc. is a Life Science Affiliate of General Atomics. Using its patented enzyme and immunoassay technology, Diazyme creates user-friendly diagnostic test reagents that may be used with automated chemistry analyzers and chemiluminescence equipment.

Author Credits:  Radhika Pawar


  • Report ID: 5472
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of clostridium diagnostics is evaluated at USD 3.66 billion.

The clostridium diagnostics market size was valued at USD 3.32 billion in 2024 and is anticipated to exceed USD 15.71 billion by the end of 2037, expanding at over 12.7% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by rising advancement in technology for clostridium diagnostics, the surge in the prevalence of foodborne illness, and the rising use of AI to launch drugs for clostridium.

North America industry is likely to hold largest revenue share 30% by 2037, impelled by rising healthcare infrastructure in the region.

The major players in the market are Cerebriu, Diazyme Laboratories, Inc., BioMerieux, Beckman Coulter, Inc. and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample